CONSULTING SERVICES AGREEMENT
This consulting services agreement (“Agreement”), made and entered into on November 20, 2006 and
effective as of the 1 st day of December 2006, by and between CytoCore, Inc. with its principal place of business
at 414 North Orleans Court, Suite 502 in Chicago, Illinois 60610 (the “Company”) and EBM, Inc., with his
mailing address of 171 E. 90 th Street, Unit 4C, New York, New York 10128, telephone (212) 348-1880) (the
The Consultant provides a variety of financial and business consulting services as part of his regular business
with EBM, Inc., and is ready, willing, and able to provide such consulting assistance to the Company on the
terms and conditions set forth herein.
The Company is in the process of developing a series of medical devices, drug delivery systems, and other
cervical and uterine cancer related medical systems. In pursuit of its business strategy the Company desires to
retain the services of the Consultant under the terms and conditions set forth herein.
NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, the Company and the Consultant agree as follows:
1 of 6
1. Engagement and Scope of Services .
1.1 Company hereby retains consultant and Consultant agrees to provide to the Company the consulting
services which are more fully described below:
Consulting with the Company’s Chief Executive Officer, Chief Financial Officer, Medical Advisory Board,
other Officers, or other consultants related to or regarding certain business plans, operations,
commercialization of medical devices or theories, and other business matters that fall within the
Consultant’s area of expertise.
Consultant will have no authority or responsibility with regard to execution of any contract on behalf of the
Company. Consultant is not an employee or officer of the Company.
Consultant will provide progres